VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 112 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $413,751 | -61.8% | 44,157 | 0.0% | 0.00% | -62.5% |
| Q2 2023 | $1,083,171 | +13.3% | 44,157 | +17.0% | 0.01% | 0.0% |
| Q4 2022 | $955,630 | +31.3% | 37,757 | 0.0% | 0.01% | +33.3% |
| Q3 2022 | $727,955 | -24.3% | 37,757 | 0.0% | 0.01% | -25.0% |
| Q2 2022 | $961,671 | +12.7% | 37,757 | +13.8% | 0.01% | +33.3% |
| Q1 2022 | $853,287 | -5.8% | 33,176 | +53.3% | 0.01% | -25.0% |
| Q4 2021 | $906,151 | -3.8% | 21,642 | 0.0% | 0.01% | -11.1% |
| Q3 2021 | $941,860 | -9.8% | 21,642 | +6.2% | 0.01% | -10.0% |
| Q1 2021 | $1,044,472 | +70.6% | 20,372 | -10.9% | 0.01% | +66.7% |
| Q4 2020 | $612,084 | -22.0% | 22,856 | 0.0% | 0.01% | -33.3% |
| Q3 2020 | $784,646 | -7.0% | 22,856 | +11.0% | 0.01% | -10.0% |
| Q2 2020 | $843,286 | +627.6% | 20,583 | +508.6% | 0.01% | +400.0% |
| Q1 2020 | $115,901 | – | 3,382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |